Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Bone Marrow Transplant. 2021 Jan 8;56(6):1373–1380. doi: 10.1038/s41409-020-01195-5

Table 2.

Response at 6 months, 1 year and 2 years.

6 months
1 year
2 years
MSD
(n = 104)
UCBT
(n = 41)
p MSD
(n = 98)
UCBT
(n = 40)
p MSD
(n = 90)
UCBT
(n = 36)
p
CR + PR 81 (78%) 32 (78%) 0.98 68 (69%) 29 (73%) 0.72 60 (67%) 24 (67%) 0.99
CR 1 (1%) 2 (5%) 0.19 5 (5%) 4 (10%) 0.28 11 (14%) 11 (33%) 0.02
Other 23 (22%) 9 (22%) 30 (31%) 11 (28%) 30 (33%) 12 (33%)

Other includes following: mixed response, flare, progression, death or relapse of underlying malignancy.

MSD matched sibling donor, UCBT umbilical cord blood transplant, CR complete response, PR partial response